- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Diagnosis and biomarkers of predementia in Alzheimer's disease ; volume:8 ; number:1 ; day:22 ; month:12 ; year:2010 ; pages:1-14 ; date:12.2010
BMC medicine ; 8, Heft 1 (22.12.2010), 1-14, 12.2010
- Urheber
-
Forlenza, Orestes V.
- Beteiligte Personen und Organisationen
-
Diniz, Breno S.
Gattaz, Wagner F.
SpringerLink (Online service)
- DOI
-
10.1186/1741-7015-8-89
- URN
-
urn:nbn:de:1111-2016072223451
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Forlenza, Orestes V.
- Diniz, Breno S.
- Gattaz, Wagner F.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
Biomarkers in Alzheimer’s disease
Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability
Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Biomarkers in Alzheimer’s disease: role in early and differential diagnosis and recognition of atypical variants
Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer’s disease
Leveraging Diverse Regulated Cell Death Patterns to Identify Diagnosis Biomarkers for Alzheimer’s Disease
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Blood‐based biomarkers for Alzheimer's disease
Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
Biomarkers in Alzheimer’s disease
Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability
Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Biomarkers in Alzheimer’s disease: role in early and differential diagnosis and recognition of atypical variants
Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer’s disease
Leveraging Diverse Regulated Cell Death Patterns to Identify Diagnosis Biomarkers for Alzheimer’s Disease
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Blood‐based biomarkers for Alzheimer's disease
Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
Biomarkers in Alzheimer’s disease
Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability
Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Biomarkers in Alzheimer’s disease: role in early and differential diagnosis and recognition of atypical variants
Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer’s disease
Leveraging Diverse Regulated Cell Death Patterns to Identify Diagnosis Biomarkers for Alzheimer’s Disease
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders